Genfit/Ipsen’s PBC Data Leave Door Open For CymaBay

 
• By Joseph Haas
  
Liver care
Competition to Intercept in second-line PBC is looming • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D